genai / news / / Devdiscourse
AstraZeneca and Roche Diagnostics have joined forces to revolutionize cancer care in Asia through a landmark three-year partnership.
AstraZeneca and Roche Diagnostics have launched a three-year AI-powered digital pathology initiative in Asia.
KEY POINTS
- This partnership is the first region-wide effort to advance computational pathology across nine Asian markets.
- Educational programs will be implemented to accelerate the adoption of digital and AI-assisted pathology.
- The initiative directly targets improving precision diagnostics for breast and lung cancer care in Asia.
COMPANIES
Summarized by Newsio from Devdiscourse. How we summarize →